Previous close | 19.28 |
Open | 19.34 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 19.16 - 19.34 |
52-week range | 19.16 - 19.34 |
Volume | |
Avg. volume | N/A |
Market cap | 274.59M |
Beta (5Y monthly) | 1.25 |
PE ratio (TTM) | 24.44 |
EPS (TTM) | 0.78 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PRESS RELEASE Quarterly financial information as of December 31, 2022IFRS - Regulated information - Audited Full year 2022 results: Revenue and investments both up 2022 revenues rose 5.8% to €555.2 millionRecurring operating income(1) came to €25.7 millionConsolidated net profit attributable to the Group came to €13.6 million Boulogne-Billancourt, France, March 23, 2022, after the market close Cegedim generated consolidated revenues of €555.2 million(3) in 2022, an increase of 5.8% as reported a
PRESS RELEASE Quarterly financial information as of December 31, 2022IFRS - Regulated information - Not audited Cegedim: Revenue growth continued in 2022 Fourth-quarter revenues grew 2.9% like for like2022 revenue amounted to €555.6 million, a 5.1% like for like increaseCegedim Santé: Double-digit growth in the second half Boulogne-Billancourt, France, January 26, 2023, after the market close Revenue Fourth quarterChange Q4 2022 / 2021Full YearChange 2022 / 2021in millions of euros20222021Report
CEGEDIM Public limited company with boards of directors with a capital of € 13 336 506,43 Registered office: 137, rue d’Aguesseau 92100 Boulogne-Billancourt350 422 622 R.C.S. on the Nanterre Trade and Companies Register Paris, January 1st 2023 Half-year liquidity contract statement for CEGEDIM Under the liquidity contract entered into between CEGEDIM and Kepler Cheuvreux, the following resources appeared on the liquidity account on December 31st 2022: 14,186 shares - € 39,036.02 Number of execut